Skip to content
Sapien FrontierSapien Frontier
LatestCompaniesFunding MapSamplePricingFor teams
Log inTry the sample →
Menu
LatestCompaniesFunding MapSamplePricingFor teamsFree weekly briefHow we work

Companies

The people and businesses moving the frontier.

Public and private companies, with evidence, commercial context and clear investment-access labels. Each profile is a living history built from SEC filings, private-offering notices and US federal award records.

All frontiersNeurotechnology & BCILongevityRegenerationGene & cell engineeringSynthetic biologyPhysical augmentationBiomonitoring
Public and privatePublicly listedPrivately held

4 companies in Physical augmentation.

Publicly listed · Nasdaq: LFWD12 developments

Lifeward

Physical augmentation · Exoskeletons and rehabilitation technology

Latest (Oct 27, 2026): Lifeward reports changes involving its directors or officers (Form 8-K, Item 5.02)

Open profile →
Publicly listed · NYSE: MYO12 developments

Myomo

Physical augmentation · Powered arm and hand orthoses

Latest (Oct 5, 2026): Department of Veterans Affairs obligates $31,635 to Myomo

Open profile →
Publicly listed · Nasdaq: VANI5 developments

Vivani Medical

Physical augmentation · Implantable drug-delivery devices

Latest (Aug 13, 2026): Vivani Medical Reports Second Quarter 2026 Financial Results and Provides Business Update

Open profile →
Privately held1 developments

Science Corp.

Neurotechnology & BCI · Physical augmentation · Neural engineering, including a retinal prosthesis

Latest (Mar 6, 2026): Science Corp. reports $230 million of securities sold in a private offering

Open profile →

Coverage is not an offer to invest. Private ownership does not imply available shares. Sector labels are Sapien Frontier’s own coverage classification, not company claims.

Missing a company? Request future coverage. We add a company when its filings, offering notices or awards can be followed reliably. See what we cover and how often.

Sapien FrontierSapien Frontier

Intelligence at the edge of human potential: longevity, neurotechnology, gene engineering and the public and private companies pursuing them, each claim tied to its source.

Research

  • Latest
  • Companies
  • Frontier Funding Map
  • The Frontier Brief
  • RSS feed

Product

  • Sample Monitor
  • Pricing
  • For teams
  • Help
  • Service status

Trust

  • Methodology
  • Coverage
  • Corrections
  • About
  • Contact
Sapien Frontier · A Quantum Economics venture.Industry intelligence, not personalized medical or investment advice. · Privacy · Terms